ARTICLE | Clinical News
DNA IL-12: Phase II started
July 16, 2012 7:00 AM UTC
OncoSec said researchers at the University of California, San Francisco, began an open-label, U.S. Phase II trial to evaluate intratumorally injected DNA IL-12 followed by electroporation using OncoSe...